This company
The company's name
Every relationship, signal and contact on this record, with the source on each.
Includes 3 days of DFX Intelligence. Then $199/month unless canceled.
What matters now
- $15.6M to $91Mprobable EBITDA
Probable EBITDA $15.6M to $91M on revenue of $520M to $1.3B, estimated from 1300 employees.
Outside the $1M to $15M EBITDA range most independent sponsors state they buy.
InferenceDFX estimate from headcount on Form 5500, 45% confidence - 38dealability of 100
Why it fits: operating tenure +8.7, 9 years since earliest plan effective date (floor on age); sector demand +10.5, specialty distribution: sponsor demand index 0.70 (anonymised market prior); benefit plans +5, 2 benefit plans on file (a professionalised employer).
The largest contributions to its dealability score, each with the fact it rests on.
DerivedDFX score, 13 Sep 2026 - 40data confidence of 100
How sure the record is: 1 independent source; latest effective observation 10 Sep 2024; size estimate at 45% confidence.
How much of this page rests on independent sources rather than on our estimates.
Measuredcount of sources and dates on the record
Specialty distribution (Drug druggist wholesale) employer in Bohemia, NY, with 1,391 benefit plan participants on its latest filing, and a benefit plan in place since 2018. No website description has been captured yet.
- +14Estimate
- +8.7Fact
- +5Fact
- +10.5Inference
No dated ownership-transition signal has been observed for this company. The transition score below rests on tenure and market pull only, which is not evidence of a sale. Do not read it as one.
- 0Inference
- 2022 to 2024Workforce on the planrisingstrong weightFactForm 5500 · read Sep 17, 2026
- Probable revenue
- $520M to $1.3B Estimate
- Probable EBITDA
- $15.6M to $91.0M Estimate
- Workforce proxy
- 1,391 plan participants
- Estimate computed on
- 1,300 employees, the headcount the size estimate used
- Method
- employees x sector revenue/employee band x sector EBITDA margin band
- Confidence
- 45%
- +15Fact1 independent source
- +11.7Factlatest effective observation 2024-09-10
- +13.5Estimate
No dated events on file.
No named leader on the record yet: the company's site did not list one where we read it.
- Founded
- benefit plan since Jan 1, 2018 (age floor 8 years)
- Ownership
- not observed
- Plans on file
- 2
| Fact | Value | Class | Effective | Source | Evidence |
|---|---|---|---|---|---|
| Active participants | 1,300 | Fact | 2024-09-10 | DOL EFAST2 Form 5500 datasets | |
| Ebitda band | $53.3M | Estimate | 2026-09-12 | DFX model output (scores, estimates, matches) no URL | |
| Hq location | Bohemia, NY | Fact | 2024-09-10 | DOL EFAST2 Form 5500 datasets | |
| Naics code | 424210 | Fact | 2024-09-10 | DOL EFAST2 Form 5500 datasets | |
| Plan count | 2 | Fact | 2024-09-10 | DOL EFAST2 Form 5500 datasets | |
| Plan effective date earliest | 2018-01-01 | Fact | 2024-09-10 | DOL EFAST2 Form 5500 datasets | |
| Plan participants | 1,391 | Fact | 2024-09-10 | DOL EFAST2 Form 5500 datasets | |
| Plan participants | 928 | Fact | 2023-01-01 | DOL EFAST2 Form 5500 datasets | |
| Plan participants | 838 | Fact | 2022-01-01 | DOL EFAST2 Form 5500 datasets | |
| Subsector | Drug druggist wholesale | Fact | 2024-09-10 | DOL EFAST2 Form 5500 datasets | |
| Vertical | Specialty distribution | Fact | 2024-09-10 | DOL EFAST2 Form 5500 datasets |